StockData
Xencor Inc logo

Xencor Inc (XNCR) bonds

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)

Close on Nov 18, 2026Market cap $2.56BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$104.90M
$27.36M due within a year
Net debt
$60.23M
After $44.66M of cash
Implied interest rate
22.53%
FY2025 interest ÷ average debt
Interest coverage
-5.6×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in Xencor's 10-Q for the period ended Aug 31, 2023

Xencor's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Letter of Credit$400.00K

See a number that looks wrong?